Entity Details

Primary name PLOD1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ02809
EntryNamePLOD1_HUMAN
FullNameProcollagen-lysine,2-oxoglutarate 5-dioxygenase 1
TaxID9606
Evidenceevidence at protein level
Length727
SequenceStatuscomplete
DateCreated1993-07-01
DateModified2021-06-02

Ontological Relatives

GenesPLOD1

GO terms

Show/Hide Table
GOName
GO:0001666 response to hypoxia
GO:0005506 iron ion binding
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0008475 procollagen-lysine 5-dioxygenase activity
GO:0008544 epidermis development
GO:0017185 peptidyl-lysine hydroxylation
GO:0030199 collagen fibril organization
GO:0030867 rough endoplasmic reticulum membrane
GO:0031418 L-ascorbic acid binding
GO:0070062 extracellular exosome
GO:1902494 catalytic complex

Subcellular Location

Show/Hide Table
Subcellular Location
Rough endoplasmic reticulum membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001006 Procollagen-lysine 5-dioxygenase, conserved siteSiteConserved site
IPR005123 Oxoglutarate/iron-dependent dioxygenaseDomainDomain
IPR006620 Prolyl 4-hydroxylase, alpha subunitDomainDomain
IPR029044 Nucleotide-diphospho-sugar transferasesFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
225400 OMIMEhlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1)A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL1 is an autosomal recessive form characterized by severe muscle hypotonia at birth, generalized joint laxity, scoliosis at birth, and scleral fragility and rupture of the ocular globe. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00126 Ascorbic acidDrugbanksmall molecule